Crescita Therapeutics (TSE:CTX) Trading Up 1.8% – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX) was up 1.8% during trading on Monday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 3,525 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 5,882 shares. The stock had previously closed at C$0.57.

Crescita Therapeutics Stock Up 1.8 %

The company has a debt-to-equity ratio of 6.02, a current ratio of 3.37 and a quick ratio of 2.29. The company has a market cap of C$11.24 million, a P/E ratio of -3.87 and a beta of 1.69. The stock has a 50-day moving average of C$0.58 and a 200 day moving average of C$0.59.

Insider Buying and Selling

In other Crescita Therapeutics news, Director Jose Darocha acquired 86,000 shares of Crescita Therapeutics stock in a transaction that occurred on Friday, December 27th. The shares were acquired at an average cost of C$0.60 per share, with a total value of C$51,436.60. 10.87% of the stock is owned by company insiders.

About Crescita Therapeutics

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.